Clinical meta-analyses have shown that resveratrol intake ameliorated NAFLD primarily through AMPK/SIRT1 and anti-inflammatory pathways [112]. This evidence concerns the gene SIRT1 and metabolic dysfunction-associated steatotic liver disease.